NCT06962657View on ClinicalTrials.gov

Mitigating Toxic Impact: The Role of Coenzyme Q10 in Post-Exposure Protection

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

July 1, 2025

Primary Completion Date

July 1, 2028

Study Completion Date

July 1, 2028

Conditions
Toxicant Induced Chronic Multisymptom Illness and Associated Symptoms and Comorbidities
Interventions
DIETARY_SUPPLEMENT

Ubiquinone 100 mg Oral Soft Gel

Active comparator arm receives three ubiquinone 100mg soft gels per day. Supplement is taken orally in divided doses, with the last soft gel not close to bedtime.

DIETARY_SUPPLEMENT

Placebo

Placebo comparator arm receives three placebo soft gels per day. Supplement is taken orally in divided doses, with the last soft gel not close to bedtime.

Trial Locations (1)

92093

UC San Diego, La Jolla

All Listed Sponsors
lead

University of California, San Diego

OTHER